Physician
Spring Valley Medical Center
Spring Valley Medical Center was paid $1.33M by Medicaid between Dec 2020 and Dec 2024, across 62 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoSPRING VALLEY MEDICAL CENTER
LAS VEGAS, NV 89178
LAS VEGAS, NV 89178
33aNPI1588219117assigned 08/09/2019
33bProvider typeEmergency Medicine Physician
28Total paid$1.33M
24GClaims59,342
24DCodes billed62
24AFirst – last monthDec 2020 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Nevada
Rank by total paid#14 of 216
Median peer was paid$63K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 52 | $0.00 | |
| 2021 | 10,685 | $138K | |
| 2022 | 18,748 | $377K | |
| 2023 | 15,927 | $411K | |
| 2024incomplete | 13,930 | $402K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 3,885 | 3,358 | $306K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 3,119 | 2,613 | $293K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 4,034 | 3,569 | $200K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.1% | 590 | 510 | $121K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.2% | 2,504 | 2,028 | $70K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.7% | 687 | 666 | $50K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 1,284 | 1,095 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.4% | 1,759 | 1,419 | $32K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 680 | 572 | $22K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 241 | 217 | $17K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 1,808 | 1,484 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 851 | 800 | $15K |
50 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 892 | $13K |
| 80053 | Comprehensive metabolic panel | <1% | 2,749 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,866 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 735 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,707 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,026 | $11K |
| 84484 | <1% | 2,213 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,977 | $8K |
| 84702 | <1% | 1,295 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,175 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 211 | $6K |
| 83690 | <1% | 1,692 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,176 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,023 | $3K |
| 81025 | <1% | 1,217 | $3K | |
| 81001 | <1% | 2,313 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,856 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 97 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 772 | $2K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 15 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 16 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 684 | $2K |
| 83605 | <1% | 363 | $1K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 31 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 275 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 26 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,044 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,092 | $978.80 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 30 | $946.11 |
| 85379 | <1% | 153 | $611.79 | |
| 81003 | <1% | 700 | $567.65 | |
| 87077 | <1% | 113 | $503.50 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,464 | $450.55 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 31 | $447.21 |
| 85610 | <1% | 298 | $311.67 | |
| 85730 | <1% | 192 | $301.46 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 15 | $290.76 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15 | $290.16 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $290.16 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 56 | $260.49 |
| 83880 | <1% | 16 | $186.66 | |
| 83735 | <1% | 63 | $175.48 | |
| 73610 | <1% | 12 | $109.02 | |
| 87186 | <1% | 34 | $107.28 | |
| 85027 | <1% | 33 | $102.24 | |
| 82550 | <1% | 13 | $53.67 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 44 | $29.73 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 17 | $23.64 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 33 | $23.24 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 15 | $0.15 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (EXECUTIVE VP-CFO)
Parent organizationSPRING VALLEY MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.